Study Overview The research investigates the potential of berberine and curcumin as therapeutic agents for multiple sclerosis (MS) by focusing […]
Autoimmune Nodopathies Classification Autoimmune nodopathies represent a diverse group of disorders characterized by inflammation and tissue damage caused by the
Autoimmune nodopathies: a clinical review Read Post »
Role of B Cells in Demyelination B cells play a pivotal role in the pathology of demyelinating diseases, such as
Understanding Fibrocartilaginous Embolism Fibrocartilaginous embolism is a condition marked by the sudden obstruction of blood vessels due to small fragments
When the Disc Strikes: Rethinking Fibrocartilaginous Embolism Read Post »
Study Overview The exploration of tumefactive demyelinating disorders reveals these conditions as compelling mimics of neoplastic processes, often leading to
Ocrelizumab and Colitis Risk Ocrelizumab is a monoclonal antibody primarily utilized in the treatment of multiple sclerosis (MS) and certain
Ocrelizumab-induced colitis acutely managed with ciclosporin Read Post »
Plasmapheresis Mechanism in MOGAD Plasmapheresis, also known as therapeutic plasma exchange, involves the removal and replacement of a patient’s plasma,
Study Overview This study investigates the phenomenon of tumefactive demyelinating disorders, which can often masquerade as neoplasms on imaging studies.
Study Overview This study aimed to investigate the relationship between anti-CD20 B cell depletion therapies and the presence of circulating
Background and Rationale Ocrelizumab is a monoclonal antibody approved for the treatment of primary progressive multiple sclerosis (PPMS) and relapsing
Ocrelizumab-induced colitis acutely managed with ciclosporin Read Post »
